News Aarti Drugs Limited NSE India S.E.

Equities

AARTIDRUGS

INE767A01016

Delayed NSE India S.E. Other stock markets 01:18:04 2024-04-19 am EDT			5-day change	1st Jan Change
490 ^INR	-0.48%		-2.78%	+0.20%

Mar. 29	Aarti Drugs Limited Announces Executive Cessation	CI
Jan. 31	Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aarti Drugs Limited Announces Executive Cessation	Mar. 29	CI
Ex-dividend day for interim dividend	Feb. 05	FA
Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility	Jan. 30	MT
Aarti Drugs Limited Initiates Commercial Production of Dermatology Product At New Facility in Tarapur, Maharashtra	Jan. 30	CI
Transcript : Aarti Drugs Limited, Q3 2024 Earnings Call, Jan 25, 2024	Jan. 25
Aarti Drugs Limited Announces Interim Dividend for the Financial Year 2023- 24	Jan. 24	CI
Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 24	CI
Transcript : Aarti Drugs Limited, Q2 2024 Earnings Call, Oct 20, 2023	23-10-20
Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-19	CI
Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on July 21, 2023.	23-08-28	CI
Aarti Drugs Limited's Equity Buyback announced on July 21, 2023, has closed with 665,000 shares, representing 0.72% for INR 598.5 million.	23-08-16	CI
Aarti Drugs Clocks Gains in Fiscal Q1 Consolidated Profit	23-07-24	MT
Transcript : Aarti Drugs Limited, Q1 2024 Earnings Call, Jul 24, 2023	23-07-24
Aarti Drugs Limited announces an Equity Buyback for 665,000 shares, representing 0.72% for INR 598.5 million.	23-07-21	CI
Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-21	CI
Aarti Drugs Limited authorizes a Buyback Plan.	23-07-20	CI
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.	23-07-14	CI
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.	23-07-14	CI
Transcript : Aarti Drugs Limited, Q4 2023 Earnings Call, May 02, 2023	23-05-02
Aarti Drugs' Consolidated Profit Climbs in Fiscal Q4	23-05-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aarti Drugs Limited NSE India S.E.

Equities

AARTIDRUGS

INE767A01016

Summary

Filters